The Duke-Industry Statistics Symposium Organizing Committee is happy to announce that the upcoming Duke-Industry Statistics Symposium (DISS2023, https://sites.duke.edu/diss/) will be held virtually March 29-31, 2023 with the theme “Empower Clinical Development by Harnessing Data from Diverse Sources”. Information about the program schedule, short courses, speakers, talk abstracts, poster submission, and registration can be found on the DISS2023 Website.
The first day of the virtual symposium will be devoted to 4 short courses. The following day and a half will consist of 2 keynote speeches, parallel sessions, and poster lightning talk sessions. Dr. John Concato, the Associate Director for Real-World Evidence Analytics in the Office of Medical Policy, FDA/CDER, will give a keynote speech on Regulatory Perspectives on Real-World Data on March 30. Dr. Demissie Alemayehu, the Vice President of Pfizer Biostatistics, will give the second keynote speech on March 31 on Enhancing Generalizability of Clinical Trial Results through Use of Real-World Evidence and Digital Solutions to Improve Enrollment Diversity. The virtual symposium will be free to all undergraduate and graduate students with majors in statistics, biostatistics, and data sciences with viable credentials. Please reach out to Judy Adkins at judy.adkins@duke.edu if you have further questions.